Passive Sensor Identification of Digital Biomarkers to Assess Effects of Orally Administered Nicotinamide Riboside
This study is recruiting. It focuses on mental health and currently lists participation information in the United States.
In Belmont
Public study records, presented in a clearer and more patient-friendly format for mental health research discovery.
This study is recruiting. It focuses on mental health and currently lists participation information in the United States.
In BelmontThis study is recruiting. It focuses on addiction and currently lists participation information in the United States.
In ShrewsburyThis study is recruiting. It focuses on PTSD and currently lists participation information in Denmark.
In Ballerup MunicipalityThis study is recruiting. It focuses on PTSD and currently lists participation information in the United States.
In ChicagoThis study is recruiting. It focuses on mental health and currently lists participation information in the United Kingdom.
In United KingdomThis study is recruiting in Canada. It is testing Patient-oriented Randomized Pragmatic Feasibility Trial with RTMS for depression.
In VancouverThis study is recruiting. It focuses on depression and currently lists participation information in the United Kingdom.
In United KingdomThis study is recruiting in the United Kingdom. It focuses on depression.
In United KingdomThis study is recruiting. It focuses on schizophrenia and currently lists participation information in France.
In BrestThis study is recruiting. It focuses on depression and currently lists participation information in the United States.
Multiple locations, including MilfordThis study is recruiting. It focuses on depression and currently lists participation information in the United States.
In MinneapolisThis study is recruiting. It focuses on PTSD and currently lists participation information in the United States.
In Winston-SalemHopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.